Literature DB >> 18224475

EGFR as a Prognostic Marker for Gastric Cancer.

Theodore Liakakos, Nikolaos Xeropotamos, Dimosthenis Ziogas, Dimitrios Roukos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18224475     DOI： 10.1007/s00268-007-9434-3

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  29 in total

1.  Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations.

Authors:  Dimitrios H Roukos; Niki J Agnanti; Evangelos Paraskevaidis; Angelos M Kappas
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  Role of surgery in the prophylaxis of hereditary cancer syndromes.

Authors:  Dimitrios H Roukos; Aggelos M Kappas; Epameinondas Tsianos
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

3.  Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.

Authors:  Niki J Agnantis; Evangelos Paraskevaidis; Dimitrios Roukos
Journal:  Ann Surg Oncol       Date:  2004-11-15       Impact factor: 5.344

4.  Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

5.  Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?

Authors:  Evangelos Briasoulis; Michael Fatouros; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

6.  HER2 and response to paclitaxel in node-positive breast cancer.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

Review 7.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

8.  Novel targets in gastric and esophageal cancer.

Authors:  Claudia María Valverde; Teresa Macarulla; Esther Casado; Francisco Javier Ramos; Erika Martinelli; Josep Tabernero
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-10       Impact factor: 6.312

9.  Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.

Authors:  Gennaro Galizia; Eva Lieto; Michele Orditura; Paolo Castellano; Anna La Mura; Vincenzo Imperatore; Margherita Pinto; Anna Zamboli; Ferdinando De Vita; Francesca Ferraraccio
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

10.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962
View more
  2 in total

1.  An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells.

Authors:  M Yashiro; H Qiu; T Hasegawa; X Zhang; T Matsuzaki; K Hirakawa
Journal:  Br J Cancer       Date:  2011-10-13       Impact factor: 7.640

2.  Expression of HER2/c-erbB-2, EGFR Protein in Gastric Carcinoma and its Clinical Significance.

Authors:  Guoxiong Cheng; Yijun Mei; Xiaoming Pan; Ming Liu; Suping Wu
Journal:  Open Life Sci       Date:  2019-05-13       Impact factor: 0.938
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.